Subjects with 3 and more risk factors of MetS showed a 69% reduction in myocardial insulin-stimulated glucose metabolism than subjects with no risk factors, and a 56.7% reduction than those with 1 or 2 components of the metabolic syndrome. This evidence concerns the gene INS and metabolic syndrome.